Ionis Pharmaceuticals (IONS) Prepaid Assets (2009 - 2026)
Ionis Pharmaceuticals (IONS) posted quarterly Prepaid Assets of $327.0 million for Q2 2026, up 44.63% year-over-year from $226.1 million in Q2 2025, and up 6.84% quarter-over-quarter from $306.1 million in Q1 2026.
Ionis Pharmaceuticals (IONS) Prepaid Assets (2009 - 2026) Analysis & Trends
Ionis Pharmaceuticals' Prepaid Assets history runs 18 years deep, the most recent figure standing at $327.0 million for Q2 2026.
- In Q2 2026, Prepaid Assets rose 44.63% year-over-year to $327.0 million; the TTM figure through Jun 2026 stood at $327.0 million (up 44.63% YoY), while the FY2025 annual figure was $237.1 million, up 8.79% from the prior year.
- Prepaid Assets for Q2 2026 stood at $327.0 million, up from $306.1 million in the prior quarter.
- The five-year high for Prepaid Assets was $327.0 million in Q2 2026, with the low at $142.8 million in Q2 2022.
- The 5-year median for Prepaid Assets is $189.5 million (2024), against an average of $203.5 million.
- The sharpest annual moves came in 2024 and 2026: Prepaid Assets climbed 1.72% in 2024, then soared 44.63% in 2026.
- Ionis Pharmaceuticals' Prepaid Assets stood at $168.3 million in 2022, then rose by 22.1% to $205.4 million in 2023, then advanced by 6.09% to $217.9 million in 2024, then rose by 8.79% to $237.1 million in 2025, then surged by 37.93% to $327.0 million in 2026.
- Business Quant data shows IONS's Prepaid Assets at $327.0 million in Q2 2026, $306.1 million in Q1 2026, and $237.1 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Ionis Pharmaceuticals | 9.48 Bn | 7.43 Bn | 265.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 327.01 Mn |
| Mar 31, 2026 | 306.08 Mn |
| Dec 31, 2025 | 237.09 Mn |
| Sep 30, 2025 | 243.74 Mn |
| Jun 30, 2025 | 226.11 Mn |
| Mar 31, 2025 | 222.57 Mn |
| Dec 31, 2024 | 217.93 Mn |
| Sep 30, 2024 | 184.19 Mn |
| Jun 30, 2024 | 194.72 Mn |
| Mar 31, 2024 | 174.06 Mn |
| Dec 31, 2023 | 205.43 Mn |
| Sep 30, 2023 | 181.08 Mn |
| Jun 30, 2023 | 177.87 Mn |
| Mar 31, 2023 | 159.72 Mn |
| Dec 31, 2022 | 168.25 Mn |
| Sep 30, 2022 | 143.17 Mn |
| Jun 30, 2022 | 142.76 Mn |
| Mar 31, 2022 | 150.58 Mn |
| Dec 31, 2021 | 143.37 Mn |
| Sep 30, 2021 | 136.64 Mn |